← Back to patent-cliff list
CAS 56469-12-6
3-hydroxy-5-(2-methyloctan-2-yl)-8-oxatricyclo[8.4.0.0(2,7)]tetradeca-1(10),2(7),3,5-tetraene-9,13-dione
Codes: Nabilone-005
Application context (from source-drug indications)
PruritusNabiloneEnd-stage renal diseaseNabiloneNauseaNabilone呕吐NabiloneObsessive-compulsive disorderNabiloneSuicidal ideationNabilone
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Nabilone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,2-Dihydroxyethane→1,5-diethyl 2-acetylpentanedioate→5-(1,1-Dimethylheptyl)benzene-1,3-diol→ethyl 3-[5-hydroxy-4-methyl-7-(2-methyloctan-2-yl)-2-oxo-2H-chromen-3-yl]propanoate→3-hydroxy-5-(2-methyloctan-2-yl)-8-oxatricyclo[8.4.0.0(2,7)]tetradeca-1(10),2(7),3,5-tetraene-9,13-dione→14'-hydroxy-12'-(2-methyloctan-2-yl)-9'-oxaspiro[1,3-dioxolane-2,4'-tricyclo[8.4.0.0(2,7)]tetradecane]-1'(10'),2'(7'),11',13'-tetraen-8'-one→3-hydroxy-9,9-dimethyl-5-(2-methyloctan-2-yl)-8-oxatricyclo[8.4.0.0(2,7)]tetradeca-1(14),2(7),3,5-tetraen-13-one→Iodo(methyl)magnesium
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.